:: The Hong Kong Anti-Cancer Society 香 港 防 癌 會 ::
p21-activated kinase 4: a prognostic and therapeutic target for ovarian carcinoma? p21活化蛋白激酶 4 (Pak4): 卵巢癌預後和治療的靶向? Inflammation related gene discovery in NPC patients treated with an anti-inflammatory drug – Celecoxib 在使用 CELECOXIB ......